Orexin receptor antagonists and insomnia treatment: state of the art

被引：0
|
作者：
Gotter, A. L. [1 ]
Coleman, P. J. [2 ]
Kuduk, S. D. [2 ]
Tannenbaum, P. L. [1 ]
Struyk, A. [3 ]
Wrishko, R. E. [4 ]
Connor, K. M. [5 ]
Herring, W. J. [5 ]
Renger, J. J. [1 ]
Winrow, C. J. [1 ]
机构：
[1] Merck Res Labs, Dept Neurosci, West Point, PA USA
[2] Merck Res Labs, Dept Med Chem, West Point, PA USA
[3] Merck Res Labs, Dept Clin Pharmacol & Expt Therapeut, West Point, PA USA
[4] Merck Res Labs, Dept Pharmacokinet & Drug Metab, West Point, PA USA
[5] Merck Res Labs, Dept Clin Res, West Point, PA USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70211-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S.27.02
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [31] Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
    Xue, Tao
    Wu, Xin
    Li, Jiaxuan
    Chen, Shujun
    Wang, Zilan
    Tan, Xin
    Wang, Zhong
    Zhang, Jianguo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [32] Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia
    Banerjee, Indrajit
    NEPAL JOURNAL OF EPIDEMIOLOGY, 2018, 8 (01): : 713 - 715
  • [33] From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia
    Mezeiova, Eva
    Janockova, Jana
    Konecny, Jan
    Kobrlova, Tereza
    Benkova, Marketa
    Dolezal, Rafael
    Prchal, Lukas
    Karasova-Zdarova, Jana
    Soukup, Ondrej
    Korabecny, Jan
    BIOORGANIC CHEMISTRY, 2020, 103
  • [34] Discovery of novel substituted octahydropyrrolo[3,4-c]pyrroles as dual orexin receptor antagonists for insomnia treatment
    Wu, Songliang
    Sun, Yu
    Hu, Yi
    Zhang, Hongmei
    Hou, Lijuan
    Liu, Xing
    Li, Yufeng
    He, Haiying
    Luo, Zhi
    Chen, Yuan
    Wang, Yuhe
    Shi, Weihua
    Shen, Liang
    Cao, Changqing
    Liang, Wei
    Xu, Qing
    Lv, Qiang
    Lan, Jiong
    Li, Jian
    Chen, Shuhui
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (06) : 1458 - 1462
  • [35] Selective orexin receptor antagonists
    Lebold, Terry P.
    Bonaventure, Pascal
    Shireman, Brock T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4761 - 4769
  • [36] Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy
    Sheibani, Mohammad
    Shayan, Maryam
    Khalilzadeh, Mina
    Ghasemi, Mehdi
    Dehpour, Ahmad Reza
    NEUROPEPTIDES, 2023, 99
  • [37] Evidence-based insomnia treatment strategy using novel orexin antagonists: A review
    Kishi, Taro
    Nishida, Maika
    Koebis, Michinori
    Taninaga, Takehiro
    Muramoto, Kenzo
    Kubota, Naoki
    Moline, Margaret
    Sakuma, Kenji
    Okuya, Makoto
    Nomura, Ikuo
    Iwata, Nakao
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2021, 41 (04) : 450 - 458
  • [38] Orexin, orexin receptor antagonists and central cardiovascular control
    Carrive, Pascal
    FRONTIERS IN NEUROSCIENCE, 2013, 7
  • [39] Innovations in Insomnia Management: A Review of Current Approaches and Novel Targets Including Orexin Receptor Antagonists
    Patel, Raj
    Quinn, Ryann
    Silver, Jonathan
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (01) : E28 - E35
  • [40] Orexin receptor antagonism for treatment of insomnia A randomized clinical trial of suvorexant
    Herring, W. Joseph
    Snyder, Ellen
    Budd, Kerry
    Hutzelmann, Jill
    Snavely, Duane
    Liu, Kenneth
    Lines, Christopher
    Roth, Thomas
    Michelson, David
    NEUROLOGY, 2012, 79 (23) : 2265 - 2274
12345